Provided by Tiger Trade Technology Pte. Ltd.

3SBIO

15.540
-0.610-3.78%
Volume:35.81M
Turnover:559.08M
Market Cap:39.29B
PE:3.88
High:16.120
Open:16.120
Low:15.480
Close:16.150
52wk High:36.264
52wk Low:14.594
Shares:2.53B
HK Float Shares:2.53B
Volume Ratio:2.41
T/O Rate:1.42%
Dividend:0.26
Dividend Rate:1.69%
EPS(LYR):4.006
ROE:35.88%
ROA:22.68%
PB:1.22
PE(LYR):3.88
PS:1.88

Loading ...

Earning Preview: 3SBIO Q2 revenue expected to increase, institutional views are mixed-to-cautious

Earnings Agent
·
Aug 13

Movement Alert|3SBIO Rises 5.18% in Regular Trading, Interim Results Review Approaching with Broker Top Pick Catalyst

Market Focus
·
Aug 10

GRAND PHARMA (00512) Secures FDA Fast Track for Its Independently Developed Global First-in-Class RDC Diagnostic for Solid Tumors

Stock News
·
Aug 09

3SBio Schedules 20 August 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend

Bulletin Express
·
Aug 07

3SBio Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 07

3SBio Issues Additional 0.16 Million Shares After Option Exercise; Total Outstanding Reaches 2.53 Billion

Bulletin Express
·
Aug 04

Movement Alert|3SBio Rises 5.51% in Regular Trading, Biotech Sector Rally Combined with Oversold Rebound

Market Focus
·
Jul 20

Movement Alert|3SBio Falls 5.64% in Regular Trading, Institutional Selling Compounds Biotech Sector Pullback

Market Focus
·
Jul 17

Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access

Stock News
·
Jul 15

Movement Alert|3SBio Rises 5.64% in Regular Trading, Biotech Sector Rallies on Innovation Drug Policy Tailwinds

Market Focus
·
Jul 15

Movement Alert|3SBio Falls 5.49% in Regular Trading, Trading at 17.06 HKD

Market Focus
·
Jul 14

Movement Alert|3SBio Rises 5.53% in Regular Trading, Biotech Sector Broadly Rallies Amid Supportive Corporate Actions

Market Focus
·
Jul 10

Movement Alert|3SBio Falls 5.24% in Regular Trading, Biotechnology Sector Broadly Under Pressure

Market Focus
·
Jul 07

3SBio (SEHK:1530) Declares Final Dividend, Is The Stock Undervalued?

Simply Wall St.
·
Jul 06

Movement Alert|3SBio Rises 3.94% in Regular Trading, Innovative Drug Payment Reform Catalyst Continues Driving Sector Momentum

Market Focus
·
Jul 06

Movement Alert|3SBio Rises 6.67% in Regular Trading, Innovative Drug Payment Reform Catalyst Combined with Intensive Buybacks Extend Rally

Market Focus
·
Jul 03

3SBio Executes 8.52 Million-Share Buy-back in June, Cutting Issued Shares to 2.53 Billion

Bulletin Express
·
Jul 02

Movement Alert|3SBio Rises 11.78% in Regular Trading, Intensive Buybacks and Sector Momentum Drive Shares Higher on Heavy Volume

Market Focus
·
Jul 02

Movement Alert|3SBio Rises 5.66% in Regular Trading, Consecutive Large-Scale Buybacks Boost Market Confidence

Market Focus
·
Jun 29

3SBio AGM Endorses HK$0.25 Final Dividend, Passes All Resolutions and Appoints KPMG as Auditor

Bulletin Express
·
Jun 25